Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 233.00
+4.00 (1.75%)
At close: Mar 6, 2026
Perseus Proteomics Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Revenue | 140.41 | 120 | 100 | 94 | 71 | 67 | Upgrade
|
| Revenue Growth (YoY) | 26.06% | 20.00% | 6.38% | 32.39% | 5.97% | -21.18% | Upgrade
|
| Cost of Revenue | 19.36 | 16 | 13 | 7 | 5 | 4 | Upgrade
|
| Gross Profit | 121.05 | 104 | 87 | 87 | 66 | 63 | Upgrade
|
| Selling, General & Admin | 899.99 | 336 | 366 | 290 | 231 | 162 | Upgrade
|
| Research & Development | -9.25 | 594 | 616 | 494 | 308 | 313 | Upgrade
|
| Operating Expenses | 890.74 | 930 | 982 | 784 | 539 | 475 | Upgrade
|
| Operating Income | -769.69 | -826 | -895 | -697 | -473 | -412 | Upgrade
|
| Interest & Investment Income | 4.64 | 1 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.7 | -2 | 16 | 7 | 9 | 1 | Upgrade
|
| Other Non Operating Income (Expenses) | 51.82 | -3 | -1 | - | -19 | - | Upgrade
|
| EBT Excluding Unusual Items | -714.93 | -830 | -880 | -690 | -483 | -411 | Upgrade
|
| Asset Writedown | -41.13 | -72 | -153 | -95 | -117 | -1 | Upgrade
|
| Other Unusual Items | - | - | -70 | - | 2 | - | Upgrade
|
| Pretax Income | -756.06 | -902 | -1,103 | -785 | -598 | -412 | Upgrade
|
| Income Tax Expense | 2.06 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Net Income | -758.12 | -904 | -1,104 | -786 | -599 | -413 | Upgrade
|
| Net Income to Common | -758.12 | -904 | -1,104 | -786 | -599 | -413 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 14 | 12 | 12 | 11 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 14 | 12 | 12 | 11 | 7 | Upgrade
|
| Shares Change (YoY) | 0.03% | 21.05% | 0.24% | 6.94% | 57.10% | 13.88% | Upgrade
|
| EPS (Basic) | -51.41 | -63.35 | -93.65 | -66.84 | -54.47 | -59.00 | Upgrade
|
| EPS (Diluted) | -51.41 | -63.35 | -93.65 | -66.84 | -54.47 | -59.00 | Upgrade
|
| Free Cash Flow | - | -794 | -976 | -728 | -509 | -424 | Upgrade
|
| Free Cash Flow Per Share | - | -55.65 | -82.80 | -61.91 | -46.29 | -60.57 | Upgrade
|
| Gross Margin | 86.21% | 86.67% | 87.00% | 92.55% | 92.96% | 94.03% | Upgrade
|
| Operating Margin | -548.18% | -688.33% | -895.00% | -741.49% | -666.20% | -614.93% | Upgrade
|
| Profit Margin | -539.94% | -753.33% | -1104.00% | -836.17% | -843.66% | -616.42% | Upgrade
|
| Free Cash Flow Margin | - | -661.67% | -976.00% | -774.47% | -716.90% | -632.84% | Upgrade
|
| EBITDA | - | -824 | -892 | -692 | -471 | - | Upgrade
|
| D&A For EBITDA | 1.25 | 2 | 3 | 5 | 2 | - | Upgrade
|
| EBIT | -769.69 | -826 | -895 | -697 | -473 | -412 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.